Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal-Reference-Cited by-同舟云学术

Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal

Published:2019-10-01 Issue:10 Volume:29 Page:1371-1379
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Van Tassell Benjamin¹,Wohlford George F.¹,Linderman Joyce D.²,Smith Sheila²,Yavuz Sahzene³,Pucino Frank⁴,Celi Francesco S.³

Affiliation:

1. Department of Pharmacotherapy and Outcomes Sciences; Virginia Commonwealth University, Richmond, Virginia.

2. Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

3. Division of Endocrinology Diabetes and Metabolism, Virginia Commonwealth University, Richmond, Virginia.

4. Food and Drug Administration, Silver Spring, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0101

Reference40 articles.

1. The Colorado Thyroid Disease Prevalence Study

2. The epidemiology of thyroid disease

3. A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism

4. Relation of Subclinical Hypothyroidism is Associated With Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk

5. Subclinical Hypothyroidism and the Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LT4/LT3 Combination Therapy vs. Monotherapy with LT4 for Persistent Symptoms of Hypothyroidism: A Systematic Review;International Journal of Molecular Sciences;2024-08-25

2. Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells;Cancer Cell;2024-08

3. Thyroid Hormone Suppresses Medulloblastoma Progression Through Promoting Terminal Differentiation of Tumor Cells;2024-02-15

4. Emerging Therapies in Hypothyroidism;Annual Review of Medicine;2024-01-29

5. Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial;BMC Endocrine Disorders;2023-08-28